ziprasidone has been researched along with Sensitivity and Specificity in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (64.29) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bies, RR; Graff-Guerrero, A; Mamo, DC; Mimura, M; Pollock, BG; Suzuki, T; Tsuboi, T; Uchida, H | 1 |
| Conca, A; Fulgenzi, G; Ghedini, N; Mandrioli, R; Mercolini, L; Protti, M; Raggi, MA | 1 |
| Hasselstrøm, J | 1 |
| Baek, M; Ha, DJ; Kim, SJ; Koo, TS; Lee, J; Moon, H | 1 |
| Camm, JA; Eng, S; Geier, JL; Karayal, ON; Keane, M; Kolluri, S; Kremer, CM; Lewis, M; Reynolds, R; Strom, BL | 1 |
| Cooper, TB; Correll, CU; Fein, M; Suckow, RF | 1 |
| Bobes, J; Cañas, F; Mackell, J; Rejas, J | 1 |
| Härtter, S; Hiemke, C; Sachse, J | 1 |
| Aboul-Enein, HY; Al-Dirbashi, OY; Al-Odaib, A; Jacob, M; Rashed, MS | 1 |
| Harrison, DJ; Mullins, CD; Naradzay, J; Obeidat, N; Shaya, FT; Zito, JM | 1 |
| Cleveland, NR; Heard, K; Krier, S | 1 |
| Cuffel, BJ; Loebel, AD; Mullins, CD; Naradzay, J; Obeidat, NA | 1 |
| Bartlett, MG; Terry, AV; Zhang, G | 1 |
| Lu, Y; Rollema, H; Schmidt, AW; Sprouse, JS; Zorn, SH | 1 |
4 trial(s) available for ziprasidone and Sensitivity and Specificity
| Article | Year |
|---|---|
Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Piperazines; Predictive Value of Tests; Prolactin; Receptors, Dopamine D2; Risperidone; Schizophrenia; Sensitivity and Specificity; Thiazoles | 2013 |
Methodological challenges in the coding and adjudication of sudden deaths in a large simple trial with observational follow-up: the ziprasidone observational study of cardiac outcomes (ZODIAC).
Topics: Antipsychotic Agents; Benzodiazepines; Cause of Death; Clinical Coding; Death, Sudden; Death, Sudden, Cardiac; Endpoint Determination; Follow-Up Studies; Heart; Humans; Incidence; International Classification of Diseases; Olanzapine; Piperazines; Product Surveillance, Postmarketing; Research Design; Risk; Schizophrenia; Sensitivity and Specificity; Surveys and Questionnaires; Thiazoles; Time Factors; United States; United States Food and Drug Administration | 2011 |
Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain.
Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Dyskinesia, Drug-Induced; Follow-Up Studies; Haloperidol; Hospitalization; Humans; Mental Disorders; Models, Econometric; Olanzapine; Outpatients; Patient Compliance; Piperazines; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Sensitivity and Specificity; Spain; Survival Analysis; Thiazoles; Treatment Outcome; Weight Gain | 2004 |
Effect of initial ziprasidone dose on treatment persistence in schizophrenia.
Topics: Adult; Antipsychotic Agents; Chi-Square Distribution; Demography; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Piperazines; Proportional Hazards Models; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Sensitivity and Specificity; Thiazoles; Treatment Outcome | 2006 |
10 other study(ies) available for ziprasidone and Sensitivity and Specificity
| Article | Year |
|---|---|
A fast and feasible microextraction by packed sorbent (MEPS) procedure for HPLC analysis of the atypical antipsychotic ziprasidone in human plasma.
Topics: Antipsychotic Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Limit of Detection; Piperazines; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Microextraction; Thiazoles | 2014 |
Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry.
Topics: Antidepressive Agents; Antipsychotic Agents; Chemical Precipitation; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Dibenzothiazepines; Humans; Methanol; Mianserin; Mirtazapine; Piperazines; Quetiapine Fumarate; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Thiazoles; Venlafaxine Hydrochloride; Zinc Sulfate | 2011 |
Quantification of lurasidone, an atypical antipsychotic drug, in rat plasma with high-performance liquid chromatography with tandem mass spectrometry.
Topics: Acetonitriles; Animals; Antipsychotic Agents; Chromatography, High Pressure Liquid; Isoindoles; Linear Models; Lurasidone Hydrochloride; Male; Piperazines; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Thiazoles | 2011 |
Determination of plasma ziprasidone using liquid chromatography with fluorescence detection.
Topics: Antipsychotic Agents; Calibration; Chromatography, Liquid; Humans; Piperazines; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Thiazoles | 2004 |
Automated determination of ziprasidone by HPLC with column switching and spectrophotometric detection.
Topics: Adult; Automation; Benzodiazepines; Chromatography, High Pressure Liquid; Clozapine; Drug Administration Schedule; Drug Monitoring; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Reproducibility of Results; Schizophrenia; Sensitivity and Specificity; Spectrophotometry; Thiazoles; Time Factors | 2005 |
Rapid liquid chromatography-tandem mass spectrometry method for quantification of ziprasidone in human plasma.
Topics: Chromatography, Liquid; Piperazines; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Thiazoles | 2006 |
Ziprasidone, diazepam, or the combination for prevention of cocaine toxicity in a mouse model.
Topics: Animals; Cocaine; Cocaine-Related Disorders; Confidence Intervals; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Male; Mice; Mice, Inbred Strains; Piperazines; Random Allocation; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric; Survival Rate; Thiazoles | 2007 |
Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Readmission; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risk Factors; Risperidone; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Sensitivity and Specificity; Substance Withdrawal Syndrome; Survival Rate; Thiazoles | 2008 |
Determination of the lipophilic antipsychotic drug ziprasidone in rat plasma and brain tissue using liquid chromatography-tandem mass spectrometry.
Topics: Animals; Antipsychotic Agents; Brain Chemistry; Chromatography, Liquid; Linear Models; Piperazines; Rats; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Thiazoles | 2008 |
5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Chromatography, High Pressure Liquid; Clozapine; Corpus Striatum; Dopamine; Haloperidol; Male; Microdialysis; Olanzapine; Piperazines; Pirenzepine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Sensitivity and Specificity; Synaptic Transmission; Thiazoles; Time Factors | 2000 |